Ridvan Yalcin

Ridvan Yalcin

Auto-generated profile, based on publicly available information

Ridvan Yalcin

Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in Angiology
Verified
Journal Article
Closed access
MAMehmet Kadri Akboga
Mehmet Kadri Akboga
İİİBRAHİM HALİL İNANÇ
İBRAHİM HALİL İNANÇ
CSCengiz Sabanoglu
Cengiz Sabanoglu
AAAhmet Akdi
Ahmet Akdi
IYIdris Yakut
Idris Yakut
RYRidvan Yalcin
Ridvan Yalcin
Acute stent thrombosis (AST) is associated with increased morbidity and mortality. The main aim of this study was to evaluate the prognostic value of the systemic immune-inflammation index (SII) and C-reactive protein (CRP) to albumin ratio (CAR) in predicting AST and high SYNTAX score in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). The criteria of the Academic Research Consortium were used to determine definite stent thrombosis. A total of 2077 consecutive patients with ACS undergoing PCI were retrospectively enrolled. Platelet, white blood cell and neutrophil counts, as well as SII, CRP, CAR, and peak cardiac troponin I (cTnI) values were significantly higher, whereas the lymphocyte count and albumin values were significantly lower in the AST (+) group compared with the AST (−) group (P < .05). SYNTAX score showed significant positive correlations with SII (r = .429, P < .001) and CRP (r = .402, P < .001). Multivariate logistic regression analysis showed that SII and CAR, as well as age, diabetes mellitus, stent length, and peak cTnI are independent predictors of AST and high SYNTAX score. In conclusion, the SII and CAR are simple, relatively cheap, and reliable inflammatory biomarkers that can predict AST and high SYNTAX scores in ACS.

5 November 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
MAMehmet Kadri Akboga
Mehmet Kadri Akboga
ATAnkara- Turkey
Ankara- Turkey
SYSamet Yilmaz
Samet Yilmaz
RYRidvan Yalcin
Ridvan Yalcin
To evaluate the prognostic value of preprocedural CHA2DS2-VASc [congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, previous stroke or transient ischemic attack (TIA) (doubled), vascular disease, age 65–74 years, female gender] score in predicting high SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score and in-hospital mortality for non-atrial fibrillation (AF) patients presenting with non-ST elevation myocardial infarction (NSTEMI). The CHA2DS2-VASc score used to determine thromboembolic risks in AF was recently reported to predict major adverse clinical outcomes in patients with the acute coronary syndrome, irrespective of AF. A total of 906 patients with a diagnosis of NSTEMI who underwent coronary angiography were retrospectively enrolled and divided into three groups according to their SYNTAX scores (low, intermediate, and high). The CHA2DS2-VASc score of each patient was calculated. SYNTAX score had a significant positive correlation with the CHA2DS2-VASc score (r=0.320; p<0.001) in the Spearman correlation analysis. The CHA2DS2-VASc score [Odds ratio, 1.445; 95% confidence interval (CI), 1.268–1.648, p<0.001], left ventricular ejection fraction, creatinine, C-reactive protein, and high-density and low-density lipoprotein cholesterol levels were demonstrated to be independent predictors of high SYNTAX score. The CHA2DS2-VASc score [Hazard ratio (HR), 1.867; 95% CI: 1.462–2.384; p<0.001], the SYNTAX score (HR, 1.049; p=0.003), and age (HR, 1.057; p=0.002) were independently associated with higher risk of in-hospital mortality in a multiple Cox-regression model. Kaplan-Meier survival curves stratified by the CHA2DS2-VASc score (<4 vs. ≥4) also showed that higher CHA2DS2-VASc scores were associated with higher in-hospital mortality. In non-AF patients with NSTEMI, CHA2DS2-VASc and SYNTAX scores are useful for prognosis assessment and can be used to identify patients at higher risk for in-hospital mortality.

12 April 2025 in Journal of Human Hypertension
Verified
Journal Article
Open access
PDF file
ÖGÖZDEN SEÇKİN GÖBÜT
ÖZDEN SEÇKİN GÖBÜT
SÜserkan ünlü
serkan ünlü
MYMehmet Rıdvan Yalçın
Mehmet Rıdvan Yalçın
Hypertension is a major global health concern associated with significant morbidity and mortality due to its effects on target organs such as the heart, kidneys, and brain. Non-dipper hypertension, characterized by insufficient nocturnal blood pressure reduction leading to sustained hemodynamic load, is linked to higher risks of end-organ damage. This study evaluates the impact of hypertension on LA anatomy and physiomechanics and explores the association of LA strain parameters with hypertensive heart disease and nephropathy. This prospective, single-center cohort study included 135 participants: 35 healthy controls, 50 dipper hypertension, and 50 non-dipper hypertension patients. All participants underwent 24-h ABPM, biochemical analysis, and transthoracic echocardiography, including speckle-tracking echocardiography, a novel technique for LA strain analysis. LA diameter,LASr, and LAVI maximum were identified as significant parameters associated with hypertensive end-organ damage. Non-dipper hypertension was associated with significantly higher 24-h blood pressure values and reduced nocturnal dipping compared to dipper hypertension. LA strain parameters(LASr, LAScd, LASct) were significantly lower in the non-dipper group. These reductions indicate impaired left atrial mechanics and early cardiac dysfunction. Logistic regression revealed that LA diameter, LASr, and LAVI maximum were significant variables associated with hypertensive heart disease, whereas only LASr was significantly associated with hypertensive nephropathy. LA strain analysis provides valuable insights into the pathophysiology of hypertension and its complications. The findings support the use of LA parameters as cost-effective, noninvasive biomarkers for assessing associations with hypertensive heart disease and nephropathy, enabling early risk stratification. This emphasizes the importance of enhanced monitoring and tailored interventions for high-risk patients.

16 August 2018 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
AEAzmi Eyiol
Azmi Eyiol
ÇYÇAĞRI YAYLA
ÇAĞRI YAYLA
SÜserkan ünlü
serkan ünlü
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN
MCMustafa Cemri̇
Mustafa Cemri̇
BBBülent Boyaci
Bülent Boyaci
Background/aim: Acute rheumatic fever and rheumatic heart disease are major causes of morbidity and mortality in developing countries. Genetic studies have determined that the immune response in rheumatic heart disease is genetically controlled and that there is a close relationship between the gene of concern and the class II human leukocyte antigen (HLA) gene. The aim of this study was to evaluate the relationship of serum HLA-B alleles and tumor necrosis factor alpha (TNF-alpha) with rheumatic heart disease. Materials and methods: A total of 50 consecutive patients with rheumatic heart disease and 50 controls were enrolled in the study. HLA alleles were analyzed using sequence-specific primer-polymerase chain reaction and nucleotide sequencing. Results: The HLA-B35 allele was significantly more common in patients with rheumatic heart disease than the control group (P = 0.043). The HLA-B44 allele was significantly more common in control patients than in patients with rheumatic heart disease (P = 0.014). There was a significant inverse correlation between high-sensitivity C-reactive protein and mitral valve area (P = 0.001). There was no correlation between TNF-alpha levels and mitral valve area (P = 0.066). Conclusion: Our findings confirmed the association between HLA-B alleles and rheumatic heart disease.

1 January 2016 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
MAMehmet Kadri Akboğa
Mehmet Kadri Akboğa
RYRıdvan Yalçın
Rıdvan Yalçın
AŞAsife Şahinarslan
Asife Şahinarslan
CDCanan Yılmaz Demirtaş
Canan Yılmaz Demirtaş
HPHatice Paşaoğlu
Hatice Paşaoğlu
AAAdnan Abacı
Adnan Abacı
Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical, and clinical risk factors and linked to a state of chronic inflammation. YKL-40 is known as an inflammatory glycoprotein, which is secreted by various cell lines during inflammation. Thus, we aimed to assess the association of serum YKL-40 levels with the presence and severity of MS. In this prospective cross-sectional study, a total of 177 consecutive patients [n=114 MS present and n=63 MS absent] were enrolled. MS was defined according to National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. Serum YKL-40 and hs-CRP levels were measured for all participants. Serum YKL-40, hs-CRP and white blood cell count (WBC) were significantly higher in the MS present group (p<0.05). There was a graded relationship between increasing number of MS components and serum YKL-40 level (p<0.05). In addition, serum YKL-40 level was positively correlated with hs-CRP level (r=0.467, p<0.001) and WBC count (r=0.251, p=0.001). In multivariable regression analysis, serum YKL-40 [1.022 (1.011-1.033), p<0.001] and hs-CRP [1.346 (1.111-1.632), p=0.002] were remained as independent predictors for the presence of MS. In the ROC curve analysis, using a cut-off level of 147.0, YKL-40 well predicted the presence of MS with a sensitivity of 73.7% and specificity of 69.8% (AUC: 0.785; 95% CI: 0.718-0.853, p<0.001). In this study, we demonstrated that serum YKL-40 level was significantly associated with the presence of MS. According to these findings, we concluded that serum YKL-40 may be a novel and useful indicator for MS.

18 July 2023 in Angiology
Verified
Journal Article
Closed access
MAMehmet Kadri Akboga
Mehmet Kadri Akboga
İİİBRAHİM HALİL İNANÇ
İBRAHİM HALİL İNANÇ
CSCengiz Sabanoglu
Cengiz Sabanoglu
AAAhmet Akdi
Ahmet Akdi
IYIdris Yakut
Idris Yakut
RYRidvan Yalcin
Ridvan Yalcin